If You Invested $1,000 in Johnson & Johnson During the Last Recession, This Is How Much You'd Have Today
A small investment in this pharma giant during The Great Recession would have more than doubled.
Johnson & Johnson
JNJ
JNJ
$147.92
$2.71
1.9%
Price as of July 14, 2020, 4:15 p.m. EDT
View Interactive JNJ Charts
A vast and diverse health care giant, Johnson & Johnson strives to help people get well through its consumer products, pharmaceuticals, and medical devices.
Interactive Chart
News & Analysis: Johnson & Johnson
The Fool has written over 2600 articles on Johnson & Johnson.
3 Stocks I'll Be Buying When the Market Crashes Again
These three companies have the resources and the positioning to survive the harshest of economic conditions.
Is There a Coronavirus Vaccine Yet?
Companies are testing COVID-19 vaccines right now -- if all goes smoothly, more than one may get to market at “warp speed.”
3 Stocks I'm Never Selling
Amazon and two other winners will stay in my portfolio for a long time.
Will Legal Problems Bankrupt Johnson & Johnson?
The company's facing thousands of lawsuits.
Better Buy: Eli Lilly vs. Johnson & Johnson
These two healthcare behemoths have something to offer most investors.
Love Dividends? 3 Stocks You Might Want to Buy
A rising dividend stream not only hedges against inflation, it also accelerates payback on investment.
This Under-the-Radar Stock Is a Better Way to Bet on Coronavirus Vaccines
Emergent BioSolutions has become the go-to manufacturing partner for companies looking to develop vaccines for the coronavirus.
Got $3,000? Here Are 3 Cheap Dividend Stocks You Can Buy
They all pay better than the S&P 500.
Better Buy: Verizon Communications vs. Johnson & Johnson
Which blue chip dividend stock is the better overall investment?
